Philips to acquire Chinese patient monitoring company

  
Philips to broaden patient monitoring presence in China with the acquisition. Source: Philips Medical Systems 
Royal Philips Electronics has reached an agreement with the shareholders of Shenzhen Goldway Industrial to acquire all outstanding shares of the Shenzhen, China-based patient monitoring company.

Financial details of the transaction were not disclosed. The transaction is expected to close in the second quarter of 2008, upon which Goldway will become part of the patient monitoring business within the Philips Healthcare division.

Goldway offers patient monitoring solutions that range from basic standalone to more fully-equipped monitors. The acquisition will secure a broader presence in the Chinese healthcare market, which is estimated to be growing at approximately 10 percent per year, according to Philips.

“This acquisition offers us a perfect opportunity to further strengthen our position in China and to increase our presence in other emerging markets. Goldway has a track record of providing excellent medical devices that are complementary to Philips’ existing patient monitoring product base,” said Deborah DiSanzo, senior vice president and general manager of Philips’ Patient Monitoring business.

Goldway is the second largest domestic patient monitoring company in China with access to mid- and large-size hospitals throughout the country. Employing a staff of 290, the company grew its 2007 sales by approximately 30 percent, Philips said.

Royal Philips Electronics has acquired a number of companies, including Health Watch, a provider of personal emergency services, for approximately $130 million. Other acquisitions include Tomcat Systems, Respironics, Visicu, Emergin, Lifeline Systems and Raytel Cardiac Services. 

Around the web

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.

Trimed Popup
Trimed Popup